# Vor Biopharma Inc. (VOR): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/vor for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $18.26 USD |
| Market Cap | $989.4M |
| P/E (TTM) | — |
| EPS (TTM) | −$79.02 |
| 52-Week Range | $6.50 – $28.66 |
| Dividend Yield (TTM) | — |

## Dividend

VOR has no dividend payment history in our records.

## Frequently Asked Questions

### What does Vor Biopharma Inc. do?

Vor Biopharma Inc. (VOR) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is VOR's market cap?

Vor Biopharma Inc. (VOR) has a market capitalization of approximately $989.4 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does VOR pay a dividend?

No, Vor Biopharma Inc. (VOR) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is VOR profitable?

Vor Biopharma Inc. (VOR) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has VOR ever paid a dividend?

No. Dividend Data's records show no dividend payments from Vor Biopharma Inc. (VOR). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/vor
- Dividend history & safety: https://www.dividenddata.com/stocks/vor/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/vor/earnings
- Financial statements: https://www.dividenddata.com/stocks/vor/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/vor/valuation
- Peer comparison: https://www.dividenddata.com/stocks/vor/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.